IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Zenith Drugs IPO listing price is ₹ 105.15, issue price is ₹ 79.00, and currently trading at ₹ 68.50 as on June 11, 2025. Zenith Drugs IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Zenith Drugs IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Indore and caters to Pharmaceutical sector. Gretex Corporate Services is the merchant banker of Zenith Drugs IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th September 2023.
Zenith Drugs IPO offer price is ₹ 79.00 and got listed at ₹ 105.15. Read Zenith Drugs IPO details mentioned above.The IPO of Zenith Drugs Limited was listed on 27th February 2024. As of today, Zenith Drugs IPO is trading at ₹ 68.50, compared to the previous day’s close of ₹ 68.25. Read the report above for detailed IPO performance.
The issue price of Zenith Drugs IPO was ₹ 79.00 per equity share.
Zenith Drugs IPO was listed at ₹105.15 on the stock exchange on 27th February 2024. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 11, 2025, the current market price of Zenith Drugs IPO is ₹ 68.50.
The 52-week high for Zenith Drugs IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Zenith Drugs IPO listed at ₹ 105.15 against the issue price of ₹ 79.00 per equity share, showing a listing day gain/loss of 26.15 (33.10%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Zenith Drugs IPO stock moved from its listing price of ₹ 105.15 to the current price of ₹68.50 per equity share, reflecting a change of -34.85% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Zenith Drugs IPO issue date of 27th February 2024 and CMP of ₹68.50, the estimated CAGR is approximately -10.38%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 79.00
Listing Price :
₹ 105.15
Previous Day Closing
₹ 68.25
Zenith Drugs IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Zenith Drugs Financial Review Page
Merchant Banker(s) of Zenith Drugs IPO: Gretex Corporate Services Limited
Zenith Drugs IPO subscription was 179.18 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Zenith Drugs IPO listed at a listing price of 105.15 against the offer price of 79.00.
The current market price of Zenith Drugs is 68.50.
Why Us?
